Clinical Trial Update: Abatacept Bone Effects in Psoriatic Arthritis With Bone Biomarker [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating abatacept's effects on bone changes and bone biomarkers in patients with psoriatic arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• Abatacept (abatacept)

Snippet

Sponsor: University of Erlangen-Nürnberg Medical School | Conditions: Evaluate Bone Changes in Patients With PsA | Phase 4 | Status: UNKNOWN